Topics

Eli Lilly announces plans to acquire Dermira via $1.1B deal

04:59 EST 14 Jan 2020 | SmartBrief

Eli Lilly unveiled plans to acquire Dermira in a deal worth about $1.1 billion, granting Lilly access to the latter's atopic  -More

Original Article: Eli Lilly announces plans to acquire Dermira via $1.1B deal

NEXT ARTICLE

More From BioPortfolio on "Eli Lilly announces plans to acquire Dermira via $1.1B deal"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...